Cerebrovascular imaging software developer iSchemaView has received registration approval from the Japanese Association for the Advancement of Medical Equipment for its Rapid imaging software platform.
The Rapid imaging software platform relies on artificial intelligence (AI) to automate key steps in the evaluation of stroke using a variety of imaging modalities, including CT angiography and MRI. The approval allows for the distribution of the Rapid platform to hospitals throughout Japan.
